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Vesicular nucleotide transporter (VNUT) is required for active accumulation of adenosine
tri-phosphate (ATP) into vesicles for purinergic neurotransmission, however, the cell
types that express VNUT in the central nervous system remain unknown. This study
characterized VNUT expression within the mammalian retina and brain and assessed
a possible functional role in purinergic signaling. Two native isoforms of VNUT were
detected in mouse retina and brain based on RNA transcript and protein analysis.
Using immunohistochemistry, VNUT was found to co-localize with tyrosine hydroxylase
(TH) positive, dopaminergic (DA) neurons of the substantia nigra and ventral tegmental
area, however, VNUT expression in extranigral non-DA neurons was also observed.
In the retina, VNUT labeling was found to co-localize solely with TH-positive DA-cells.
In the outer retina, VNUT-positive interplexiform cell processes were in close contact
with horizontal cells and cone photoreceptor terminals, which are known to express P2
purinergic-receptors. In order to assess function, dissociated retinal neurons were loaded
with fluorescent ATP markers (Quinacrine or Mant-ATP) and the DA marker FFN102,
co-labeled with a VNUT antibody and imaged in real time. Fluorescent ATP markers and
FFN102 puncta were found to co-localize in VNUT positive neurons and upon stimulation
with high potassium, ATP marker fluorescence at the cell membrane was reduced. This
response was blocked in the presence of cadmium. These data suggest DA neurons
co-release ATP via calcium dependent exocytosis and in the retina this may modulate
the visual response by activating purine receptors on closely associated neurons.
Keywords: purinergic, extracellular adenosine tri-phosphate (eATP), vesicular nucleotide transporter (VNUT),
SLC17A9, dopamine, retinal neurons, substantia nigra, ventral tegmental area (VTA)
Introduction
Extracellular adenosine 3′-triphosphate (eATP) acts as a potent signaling molecule in various
tissues, mediating physiological and pathological responses on binding to cell surface purinergic
receptors (Burnstock, 2007; Abbracchio et al., 2009). The mechanisms by which eATP is released
continue to be heavily debated and appear to be far more varied than those described for most other
neurotransmitters. ATP eﬄux mechanisms can be broadly classified into two types: (1) conductive
mechanisms, which involve passive, osmotic diffusion into the extracellular environment via
maxi-anion channels, volume-regulated ion channels, pore-forming connexins, pannexins, and
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P2X7-receptors and; (2) exocytotic mechanisms, which involves
ATP accumulation within synaptic vesicles and active exocytosis
(Lazarowski, 2012; Mutafova-Yambolieva and Durnin, 2014).
In 2008, Sawada et al. identified a vesicular transporter for
active accumulation of ATP within synaptic vesicles (Sawada
et al., 2008). Vesicular nucleotide transporter (VNUT) protein,
encoded by the solute carrier 17, member 9 (SLC17A9) gene, was
found to be a novel member of an anion transporter family. It
was identified as a mediator of active accumulation of nucleotides
(i.e., ATP, ADP, and UTP) into secretory vesicles and was found
to be required for exocytosis of ATP from various tissue types
(Sawada et al., 2008; Iwatsuki et al., 2009; Tokunaga et al., 2010;
Sathe et al., 2011; Larsson et al., 2012; Geisler et al., 2013; Oya
et al., 2013; Sesma et al., 2013; Haanes et al., 2014; Harada and
Hiasa, 2014).
Within the retina, ATP and its breakdown products have
been implicated in modulation of a number of retinal circuits,
via actions on P1 or P2 receptors (Lohr et al., 2014). Indeed,
many ionotropic (P2X) and metabotropic (P2Y), ATP sensitive
receptor subtypes have been characterized in the retina of the
mouse (Kaneda et al., 2004; Shigematsu et al., 2007; Vessey and
Fletcher, 2012; Ho et al., 2014), rat (Puthussery and Fletcher,
2004, 2006, 2007; Ward et al., 2008; Ward and Fletcher, 2009;
Zhang et al., 2012), primate (Ishii et al., 2003; Puthussery
et al., 2006) and human (Pannicke et al., 2000; Fries et al.,
2005; Tovell and Sanderson, 2008), indicative of a role for
the purinergic system in visual processing. In the brain, ATP
has also been suggested to act as a neurotransmitter based on
the expression of purine P2X and P2Y receptors by neurons,
particularly in regions such as the hippocampus and substantia
nigra (Amadio et al., 2007; Burnstock et al., 2011). Despite the
possible importance of purinergic signaling within the CNS, the
molecular mechanism(s) responsible for ATP release in the retina
remains largely unknown.
While several lines of evidence indicate ATP release occurs via
conductive mechanisms following physiological and mechanical
stimuli (Newman and Zahs, 1998; Mitchell, 2001; Newman, 2003,
2015; Pearson et al., 2005; Reigada and Mitchell, 2005; Xia et al.,
2012), only a few studies have focused on the possibility of a
vesicular ATP release mechanism (Santos et al., 1999; Reigada
andMitchell, 2005; Loiola and Ventura, 2011). In the retina, ATP
release via exocytosis has been shown using cultures of retinal glia
(Loiola and Ventura, 2011; Newman, 2015), cholinergic neurons
(Santos et al., 1999) and retinal pigment epithelial cells (Reigada
and Mitchell, 2005). Moreover, ATP may be co-released from
amacrine cells together with classical neurotransmitters, such as
acetylcholine and GABA (Neal and Cunningham, 1994; Santos
et al., 1999), however, the source of ATP and the mechanism of
release has not been determined. Recently, Slc17a9 expression
was demonstrated in the mouse retina, suggesting that vesicular
ATP release may indeed play a role in purinergic transmission
(Vessey and Fletcher, 2012). However, the cellular location of
VNUT and consequently the source of vesicular ATP remain
to be elucidated. With the use of a novel antibody directed
against the VNUT protein, the aim of the present study was to
characterize the location and function of VNUT positive cells
within the mouse retina and brain. The results of this study
expand our understanding on the role of vesicular ATP release
in purinergic neurotransmission in the central nervous system.
Materials and Methods
Animals
All experimental procedures using animals were performed in
accordance with the recommendations of the Association of
Vision Research and Ophthalmology (ARVO) Statement for the
Use of Animals in Ophthalmic and Vision Research and The
University of Melbourne Animal Ethics Committee (Ethics #:
1112260). The protocol was approved by The University of
Melbourne Animal Ethics Committee. All rats and mice were
housed and maintained in plastic cages with ad libitum access
to food and water under a 12 h:12 h light-dark cycle. Adult
C57BL/6J mice (http://jaxmice.jax.org/strain/013636.html) and
Dark Agouti rats (male and female; 6–8 weeks old; Animal
Resources Centre, WA, Australia) were used for experimental
procedures. Mice were deeply anesthetized by intraperitoneal
injection of ketamine (130mg/kg; Provet, VIC, Australia) and
xylazine (27mg/kg; Troy Laboratories, NSW, Australia) and
sacrificed by cervical dislocation. Rats were deeply anesthetized
by intraperitoneal injection of ketamine (130mg/kg) and
xylazine (27mg/kg) and sacrificed using intraperitoneal injection
of sodium pentobarbital (120mg/kg; Provet).
Slc17a9 Variant Gene Expression
In addition to the full length Slc17a9 gene (NM_183161),
putative protein coding isoforms have recently been predicted
(transcript variants X1, XM_006500589; X2, XM_006500590;
and X3, XM_006500591). In order to determine whether any
of these variants were expressed in the mouse retina and brain,
adult (3 month old) C57Bl6J mice were euthanized (as above)
and the retina and midbrain isolated. Tissue samples were snap
frozen in liquid nitrogen and stored at −80◦C until use. Total
RNA was isolated from retinal and midbrain tissue samples
using commercial spin columns (RNeasy, Qiagen, Valencia CA)
incorporating an on-column DNase I digest to remove genomic
contamination. 500 ng of total RNAwas reverse transcribed using
a specific reverse primer (5′- GAGCAAGCAGAGCACAACTG-
3′) targeting the full length Slc17a9 gene and a commercial
reverse transcription kit (Tetro, Bioline, London, UK). The
subsequent template was amplified (MyTaq, Bioline) using
primers (forward 5′-CTTTGGCTGGAACAAGAAGG-3′;
reverse 5′-TAGTACGCCCAGAGCAAGGT-3′) that flanked the
variable region in the coding sequence for the full length, X1,
X2 and X3 transcript variants (NM_183161, XM_006500589,
XM_006500590, XM_006500591). These primers did not
distinguish between the X1 and X2 variants, as the variable
region is found in the 5′ untranslated region of the gene. The
amplified products were purified after agarose gel electrophoresis
(Qiaquick, Qiagen) and sequenced (Australian Genome
Research Facility, VIC Australia) to confirm the sequence of
Slc17a9 variants. Full length, X1, X2, and X3 transcript variants
were aligned with the sequenced products to confirm identity
and highlight the variable regions in the respective sequences
(Clustalw, http://www.genome.jp/tools/clustalw/).
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Western Blot Analysis
To determine whether the detected gene transcripts coded for
protein variants and also to ensure the specificity of the VNUT
antibody, Western blot analysis was undertaken. Isolated mouse
retinae, cortex and kidney were sonicated in homogenizing buffer
(40mM HEPES; 320mM Sucrose; pH, 7.5) containing a cocktail
of protease inhibitors (1 tablet cOmplete R© per 10mL; Roche,
VIC, Australia). Homogenates were centrifuged at 7,500 g for
1min at room temperature. The supernatants were collected
and centrifuged again at 13,000 g for 15min to separate soluble
proteins from membrane bound proteins in the pellet. A mouse
VNUT control peptide was produced from a plasmid (mus
musculus solute carrier family 17, member 9, Slc17a9 obtained
as transfection ready DNA from Origene; Rockville, MD, USA)
and produced in vitro using an EasyXpress protein Synthesis
Kit (Qiagen) according to the manufacturer’s specifications. The
membrane-bound pellets (30µg) and the VNUT peptide (4µl)
were re-suspended in homogenizing buffer and diluted with
sample buffer (0.5M Tris-HCl, pH 6.8; 10% SDS; 25% glycerol;
0.5% bromophenol blue; 0.5% beta-mercaptoethanol). Samples
were boiled for 4min then centrifuged at 13,000 g for 45 s.
Denatured protein was loaded onto 12% Acrylamide/Bis-Tris
gels along with a molecular weight marker (Odyssey R©-Licor,
Millenium Science, VIC, Australia). Proteins were separated on
the gel by electrophoresis and transferred onto nitrocellulose
membranes. The membranes were briefly stained with Ponceau
S to ensure protein transfer and then rinsed with dH2O.
Membrane-bound proteins were blocked with 1% bovine serum
albumin (BSA) and 10% normal goat serum (NGS) in Tris-
buffered saline with 0.05% Tween-20 (TBS-T) for 1 h on a rocker
at room temperature. The membranes were then incubated with
the primary antibody directed against VNUT (Guinea pig anti-
VNUT; 1:3000; EMD Millipore, Temecula, CA, USA) diluted
in 1% BSA and 3% NGS in TBS-T. As a peptide block control,
in some instances the primary antibody directed against VNUT
was pre-incubated overnight with five times the concentration
of the peptide antigen prior to application to the membranes. In
all instances, mouse-anti GAPDH (1:3000, Sigma-Aldrich, NSW,
Australia) was applied at the same time as the VNUT antibody, as
a protein loading control. After incubation in primary antibody
overnight on a rocker, membranes were washed three times
with TBS-T, incubated with the secondary antibodies (goat
anti-guinea pig 800 at 1:1000, ImmunoReagents, Raleigh, NC,
USA; goat anti-mouse 680 at 1:1000, Odyssey R©-Licor) diluted in
1% BSA and 3% NGS in TBS-T for 1 h and washed again in TBS-
T. The membranes were imaged using an Odyssey CLx Infrared
imaging system (Odyssey R©-Licor) and the same settings used for
all blots including the peptide block controls.
Immunohistochemistry
For immunohistochemistry on retinal sections, eyes were
enucleated and the anterior segment and vitreous were removed.
The posterior eyecups were then fixed in 4% paraformaldehyde
in 0.1M phosphate buffer (pH 7.4; PB) for 30min and
cryoprotected in graded sucrose (10%, 20%, 30%) in PB
overnight. For retinal sections, the tissue was embedded in
optimal cutting temperature (OCT) compound (Tissue-Tek,
Sakura, CA, USA), frozen at −20◦C, and sectioned transversely
at 14µm on a Microm HM550 cryostat (Thermo Scientific,
Walldorf, Germany). Retinal sections were collected onto
polylysine-coated slides (Thermo Scientific, VIC, Australia) and
stored at −20◦C. Indirect immunohistochemistry was used to
determine the specific location of the guinea pig anti-VNUT
antibody in sections of the transverse mouse and rat retina. For
labeling of retinal sections, frozen sections were washed in PB and
blocked with 10%NGS, 1% BSA and 0.5% Triton-X-100 in PB for
1 h. The sections were then incubated with primary antibodies
diluted in 3% NGS, 1% BSA, and 0.5% Triton X-100 in PB
overnight at room temperature. VNUT expression was assessed
using a novel guinea pig primary antibody directed against
VNUT/SLC17A9 (diluted 1:10000, EMD Millipore Temecula,
CA, USA; Cat. No.: ABN83). Dopaminergic amacrine and
interplexiform cells were labeled using a mouse primary antibody
directed against tyrosine hydroxylase (TH; diluted 1:2000, Merck
Millipore, Kilsyth, VIC, Australia; Cat. No.: MAB318). After
washing with PB, sections were incubated with secondary
antibodies (goat anti-guinea pig Alexa Fluor 488 and goat
anti-mouse Alexa Fluor 594, diluted 1:500, Life Technologies
Australia, VIC, Australia) for 1 h at room temperature in the
dark. The sections were washed in PB,mounted with fluorescence
mounting medium (Dako, NSW, Australia) and covered with
a glass coverslip. Peptide block controls were obtained by pre-
incubation of the VNUT primary antibody with the peptide
antigen (5X excess) overnight, prior to application to the retinal
sections.
For immunohistochemistry on mouse retinal wholemounts,
posterior eyecups were fixed in 4% paraformaldehyde in PB
for 30min and cryoprotected. Mouse retinae in 30% sucrose
in PB were exposed to repeated (3x) freeze-thaw cycles
before immunohistochemical processing to improve antibody
penetration. For labeling, the tissue was blocked for 1 h and
incubated in primary antibodies for 4 days at 4◦C. Horizontal
cells were labeled using a mouse anti-calbindin D28k antibody
(diluted 1:2000, Swant, Bellinzona, Switzerland; Cat. No.: 300).
Cone photoreceptor terminals were labeled using the lectin
Peanut Agglutinin Rhodamine conjugate (diluted 1:250, Vector
Labs, Burlingame, CA, USA; Cat. No.: RL-1072). Secondary
antibodies were incubated overnight at room temperature. The
retinae were dissected from eyecups, mounted onto glass slides
with fluorescence mounting medium (Dako) and coverslipped
with the ganglion cell layer side up.
For immunohistochemistry on brain slice preparations,
deeply anesthetized mice were perfused transcardially with 20ml
of 0.9% normal saline followed by the same volume of 4%
paraformaldehyde in PB. Brains were removed and postfixed in
the same fixative for 1 h at 4◦C, and were then transferred to 10%
sucrose in PB for 1 h and 30% sucrose overnight. Brains were
then frozen in OCT compound, and cryostat sections were cut
at 50µm and collected in 24-well tissue culture plates (two or
three sections per well) in PB. Cryostat brain sections containing
the substantia nigra and VTA were incubated free-floating in
guinea pig anti-VNUT (diluted 1:10000) and mouse anti-TH
(diluted 1:2000) primary antibodies for 48 h at 4◦C. After washing
in PB, sections were incubated in secondary antibodies (goat
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anti-guinea pig Alexa Fluor 488 and goat anti-mouse Alexa Fluor
594, diluted 1:500) overnight at 4◦C. They were then washed
in PB and mounted onto glass slides in fluorescence mounting
medium (Dako).
Confocal Microscopy and Image Analysis
Images were taken using the Zeiss LSM-5 confocal laser scanning
microscope (Zeiss, Oberkochen, Germany) using 10x/0.45,
20x/0.8, 40x/1.3, and 63 x/1.4 oil-immersion objectives at a
resolution of 1024 × 1024 pixels. The appropriate fluorescence
filters were used (Alexa 594/Cy3: excitation 568 nm, emission
filter 605/32; Alexa 488/FITC: excitation 488 nm, emission filter
522/32) for visualization of the fluorophores. Confocal settings
were not altered between images of retinal sections labeled with
VNUT antibody and the peptide block controls.
Confocal z-series that spanned the layers of interest in
flatmounted retinas were acquired with the optimal pinhole size
(1 Airy unit) as suggested by the software. In some cases, selected
consecutive focal planes were merged to form a single composite
image as a maximum intensity z-projection by Zeiss LSM Image
Browser software (v4.2.0.121, Zeiss). Magnifications varied, with
scale bars digitally added to the images by Zeiss LSM Image
Browser software. Two-dimensional images were adjusted when
appropriate for brightness, contrast and black levels in Adobe
Photoshop CSE Version 4 (Adobe System, CA, USA).
Three-dimensional (3D) reconstruction of flatmounted
retinas was performed using IMARIS software (x64, v.7.7.0
Bitplane AG, Zürich, Switzerland). Confocal z-stacks were
reconstructed into 3D images in the Surpass mode. Background
noise of each fluorescent channel was minimized individually
on the Display adjustments panel. In some cases, images were
cropped to the relevant part of the field without altering the
resolution. 3D representations of retinal neurons and synaptic
terminals in confocal z-stacks were created with the Surface
function. Rendered images of different magnifications were
captured using the Snapshot function and exported as Tiff files.
Antibody Characterization
The guinea pig anti-vesicular nucleotide transporter/SLC17A9
(EMDMillipore Temecula, CA, USA; Cat. No.: ABN83) is a novel
antibody corresponding to the extracellular domain of mouse
VNUT. The synthetic peptide consisting of amino acids 155–167
of murine VNUT was made at EMD Millipore (Temecula, CA,
USA). New Zealand White rabbits were immunized with a linear
synthetic peptide (SQKVQESERAFTY) conjugated to KLH via
a C-terminal cysteine. Specificity and cellular expression of this
antibody are described below in the results.
A rabbit polyclonal anti-vesicular nucleotide
transporter/SLC17A9 antibody from MBL (MBL International
Corporation, Des Plaines, IL, USA) was also tested. This antibody
was raised to human SLC17A9 isoform 2 and was expected to
cross react with rodent VNUT according to the manufacturer
specifications. This antibody gave specific labeling in the mouse
and rat retina that could be blocked by the associated peptide
antigen and Western blot of the retina and cortex revealed
binding to a single, specific band of around 70 kDa, the expected
size of VNUT (Sawada et al., 2008). However, further testing
indicated that this antibody did not recognize purified murine
VNUT inWestern blot (data not shown). In addition, sequencing
of the amino acid antigen revealed that while the peptide was
indeed specific for human VNUT isoform 2, it did not correlate
well with the mouse VNUT sequence. Only a single amino acid
out of 16 in the peptide antigen aligned within a similar region
of the mouse VNUT protein and no significant similarity was
found by NCBI blast comparison. Following these results we did
not pursue this antibody further (data not shown).
The mouse anti-calbindin D28k recognizes a specific 28-
kDa protein in Western blots of mouse brain extracts, and
immunoreactivity was absent in the cerebellum of calbindin D-
28K knockout mice (manufacturer’s data sheet). This antibody
has been shown to label horizontal cells in the retina of the mouse
(Jellali et al., 2002; Vessey and Fletcher, 2012) and salamander
(Zhang et al., 2006).
The mouse anti-GAPDH (clone GAPDH-71.1) recognizes a
single band at ∼37 kDa on Western blots corresponding to the
weight of the full length GAPDH protein using A431 total cell
extracts (manufacturer’s data sheet). A protein band of the same
size has been reported on Western blots of rat (Zabouri et al.,
2011) and mouse (Vessey and Fletcher, 2012) retinal extracts.
The mouse anti-TH recognizes a protein band of
approximately 59–61 kDa by Western blot of purified PC12
cell lysates (manufacturer’s data sheet). This antibody has been
shown to label dopaminergic neurons in the retina of the mouse
(Witkovsky et al., 2008; Yoshida et al., 2011) and rat (Puthussery
and Fletcher, 2006; Zhang et al., 2013), and in the midbrain of
the mouse (Shaw et al., 2010) and rat (Redmond et al., 2009).
Retinal Neuron Preparation for Functional
Analysis
Dissociated neuronal cells from adult C57BL/6J mice tissues
were prepared for functional analysis. For any given (n =
1) experiment, four retinae from two mice were isolated and
placed in a HEPES buffered physiological saline solution (PSS;
NaCl 137mM, KCl 2.5mM, HEPES 10mM, D-glucose 28mM,
NaH2PO4 1.25mM, MgCl2 1mM, and CaCl2 2mM). Retinal
neurons were gently dissociated using a neural dissociation
kit (MACs Miltenyi Biotec), according to the manufacturer’s
specifications and then resuspended in PSS.
ATP Release Assay
To assess whether a depolarizing stimuli induced ATP release
from dissociated retinal neurons (n = 5 separate neuronal
preparations), cells were re-suspended at a 1 × 106 cells/mL
in PSS and maintained on ice. Using the ENLITEN R© ATP
Assay (Promega, Alexandria, NSW, Australia; Cat# FF2000), ATP
release from dissociated neurons was determined according to
manufacturer’s protocol. Briefly, 5µL of ATP (10−14–10−5M)
was combined with 50µL of rL/L reagent and luminescence
measured over a 20 s epoch to generate a standard curve. To
assess ATP release from the retina, neuronal samples were
heated to 37◦C and 10µL of neuronal preparation in PSS
and 50µL of rL/L was combined with either: 1) 10µL of
PSS to assess basal ATP release or 2) 10µL of a neuron
depolarizing, 55mM K+-PSS high potassium, low sodium PSS
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(final NaCl 27mM, KCl 55mM, HEPEs 10mM, D-glucose
28mM, NaH2PO4 1.25mM, MgCl2 1mM, and CaCl2 2mM) to
assess neuronal ATP release; or 3) 10µL of 55mM K+-PSS to
depolarize neuronal preparations where voltage-gated calcium
channel-dependent synaptic transmission was blocked by pre-
incubated with 400µMCadmium (Cd++).
Fluorescent Dye Loading and Confocal Imaging
In vitro
Dissociated retinal neurons were re-suspended in PSS containing
0.5% BSA at 5 × 106 cells/mL and incubated with the
guinea pig anti-VNUT antibody (1:100) for 15min at 4◦C
and washed with 20mL of PSS. Cells were centrifuged at
130 g for 10min at 4◦C and re-suspended in 4mL of
PSS containing 0.5% BSA. A secondary goat anti-guinea pig
Alexa 594 (1:500, Life Technologies, Cat#A-11076) was applied
for 15min at 4◦C in conjunction with fluorescent dyes for
ATP-containing vesicles (Mant-ATP 50µM; Life Technologies,
Cat#M-12417 or Quinacrine 10µM, Sigma-Aldrich Australia,
Cat#Q3251) and dopamine containing vesicles (Fluorescent false
neurotransmitter, FFN102 50µM; Abcam, Sapphire Biosciences,
NSW, Australia, Cat#AB120866). The fluorescent dyes for the
ATP-containing and dopamine-containing vesicles excite in the
488 and 380 nm ranges, respectively (Dou et al., 2012; Rodriguez
et al., 2013). Cells were washed in 20mL of PSS, centrifuged at
130 g for 10min at 4◦C and re-suspended at 5×107 cells/mL and
placed on ice until imaging. A cell volume of 200µL was applied
to a glass coverslip-bottomed petri dish and the sample covered
with a small glass cover slip. Images were collected using a X63 oil
objective, with X7 times zoom on an inverted SP5 confocal laser
scanning microscope (Leica microsystems, North Ryde, NSW,
Australia), with the chamber temperature set at 37◦C. Scan speed
was optimized for image quality and still shots collected at 100Hz
and movies collected at 1400Hz.
To assess ATP release from labeled cells, neuronal
preparations in PSS were imaged over a 1min epoch in
response to: (1) No treatment, to assess for fluorescence
bleaching and basal vesicle release; (2) Administration of PSS
to assess for fluorescence bleaching and basal vesicle release
in response to changes in volume; (3) A neuron depolarizing,
55mM K+-PSS to assess vesicle release; or (4) 55mM K+-PSS to
depolarize neuronal preparations where voltage-gated calcium
channel-dependent synaptic transmission was blocked by
pre-incubation with 400µM Cadmium (Cd++). In general,
treatments were administered within the first 15–20 s of imaging
and for the purposes of analysis, slight differences in the start
time were normalized by considering only the 10 s epoch before
treatment as the start time. At least n = 5–10 cells were analyzed
per treatment from n = 6 neuronal preparations. Changes in
fluorescence intensity of puncta near the cell membrane were
assessed over time using a customized Image J 1.43 Freeware
script (NIH, USA) and normalized to average intensity at
baseline over the first 10 s prior to treatment.
Statistics
Results are expressed as the Mean± Standard Error of the Mean
(SEM). Statistical analysis was performed using Graphpad Prism
v6 (San Diego, CA, USA) and One-Way ANOVA used to assess
the effect of treatment conditions. Statistical significance between
treatments is indicated by ∗ for p < 0.05.
Results
Multiple Isoforms of the Slc17a9 Gene are
Expressed in the Mouse Retina and Brain
In addition to full length Slc17a9 sequence, an additional three
potential protein coding isoforms have been predicted (X1,
X2, and X3). Expression of Slc17a9 and the putative isoforms
were assessed in mouse retina and midbrain (Figures 1A,B).
Using primers that spanned the variable region, a 438 bp PCR
product (Figure 1A, upper band) and a smaller 368 bp PCR
product (Figure 1A, lower band) were detected in both retina
and midbrain samples. When sequenced, the 438 bp product
showed 100% identity with the full length Slc17a9 sequence
(Figure 1B, upper two gene sequences), while the smaller
product showed complete identity to the X1 and/or X2 isoforms
(Figure 1B, lower two gene sequences). As the X1 and X2
variants differ in the 5′ untranslated region of the gene, the
expression of these isoforms could not be distinguished.
Respective negative controls for retina and midbrain
samples discounted the possibility of genomic contamination
(Figure 1A).
To determine whether the detected gene transcripts coded
for protein variants, Western blot analyses on purified mouse
VNUT/SLC17A9 protein and homogenates of mouse cortex,
retina and kidney were performed. The novel guinea pig
antiserum recognized the full length purified VNUT protein,
labeling a band of ∼75 kDa (Figure 1C, left blot, plasmid).
In contrast, the reactivity was negligible when the antibody
was pre-incubated with excess antigen peptide (Figure 1D, left
blot, plasmid), indicating that the antibody was specific for
full length mouse VNUT protein. In addition, the absence
of GAPDH signals on these immunoblots suggests that the
in vitro production of VNUT peptide from plasmid resulted in
little contaminating peptide expression, reducing the chances
of false labeling. In the retinal and cortical homogenates, two
bands of ∼75 kDa and ∼50 kDa were recognized by the VNUT
antibody (Figure 1C, right blot). The larger band corresponds
to the predicted molecular weight reported in previous studies
for full length VNUT (Sawada et al., 2008; Larsson et al., 2012;
Hiasa et al., 2014). The smaller ∼50 kDa band likely represents
the smaller isoform X1/X2. Both the ∼75 kDa and ∼50 kDa
bands were eliminated when the antibody was pre-incubated in
excess peptide antigen (Figure 1D, right blot), suggesting specific
reactivity with native VNUT from mouse retina and cortex. No
labeling was observed in the kidney membrane preparations
(Figure 1C), indicating that VNUT expression is likely very low
or may be absent in mouse kidney.
VNUT is Expressed by Dopaminergic Neurons in
the Mouse Retina and Midbrain
Immunolabeling performed on a vertical section of the adult
mouse retina with the antibody against VNUT revealed selective
expression in somata in the proximal portion of the inner
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FIGURE 1 | Two native isoforms of Slc17a9/VNUT are expressed in the mouse retina and brain. Slc17a9 isoform transcript expression was assessed in
mouse retina and brain. Two protein coding Slc17a9 isoform transcripts were identified. (A) A 438 bp PCR product band (upper band), representing full length
Slc19a9, and a 368 bp band (lower band), representing isoforms X1/X2 was apparent in both retina and midbrain. (B) PCR product specificity was confirmed by
sequence alignment of a 120 bp region spanning the variable region. (C)Western blot analysis of purified full length VNUT protein incubated with guinea pig polyclonal
anti-VNUT antibody showed an immunoreactive band at ∼75 kDa (plasmid, green). In contrast, two isoforms of native VNUT were identified in retinal and cortical
homogenates at ∼50 kDa and ∼75 kDa (green). (D) VNUT immunoreactivity was blocked by pre-incubation with excess peptide antigen. Little/no VNUT labeling was
detected in mouse kidney homogenates. All immunoblots were co-labeled with GAPDH as a protein loading control (red).
nuclear layer (INL) and in labeled processes arising from the
base of somata adjacent to the INL/inner plexiform layer (IPL)
border (Figure 2A). In addition, fine VNUT immunoreactive
(VNUT-IR) processes were found to extend deeper into the IPL
(arrowheads), as well as traverse the INL and ramify in the
outer plexiform layer (OPL; arrows). These processes usually
branched from the primary dendrites in sublamina 1 of the IPL
(Figure 2A), but occasionally they arose from the cell somata.
Labeling was completely abolished with the pre-incubation of
the peptide antigen control (Figure 2B). Similar labeling patterns
were observed in the adult rat retina with the VNUT antibody
(Figure 2C) and with the pre-adsorption of the antigen peptide
(Figure 2D).
The morphology and location of the retinal VNUT-IR cells
closely resembled that of dopaminergic amacrine/interplexiform
cells (IPCs; Nguyen-Legros et al., 1997; Witkovsky, 2004). In
order to confirm this, VNUT expressing cells were co-labeled
with TH, the rate-limiting enzyme for dopamine production that
is specifically expressed by DA cells (Brecha et al., 1984; Nguyen-
Legros et al., 1984; Oyster et al., 1985). Double-immunolabeling
on a vertical section of mouse retina showed that VNUT-IR
was specifically expressed in the sparse TH-positive cells in the
INL and their processes that stratify along the outer margin of
the IPL (Figures 2E–G). In addition, a VNUT-IR interplexiform
process extending distally toward the OPL was co-localized with
TH (Figures 2E–G, arrows). Flatmount preparations imaged at
the level of the INL and IPL showed exclusive overlap between
VNUT (Figure 2H) and TH (Figure 2I) labeling of DA cell
somata and their dense network of processes in sublamina 1 of
the IPL (Figure 2J). This indicates that VNUT is expressed in all
dopaminergic amacrine/IPCs in the mouse retina.
In addition to the retina, dopaminergic neurons are located
in the substantia nigra and ventral tegmental area (VTA)
of the midbrain, which is an area involved in motor,
cognitive and emotion control (Cachope and Cheer, 2014).
To determine whether VNUT was expressed in different
populations of DA neurons of the CNS, VNUT and TH
co-labeling was performed on coronal mouse brain sections
(Figure 3A). All TH-positive DA cells in the substantia
nigra (Figures 3B–D) and VTA (Figures 3E–G) were VNUT-
positive. However, VNUT expression was not restricted to
DA neurons, such that VNUT+TH− cells were found in the
substantia nigra (Figures 3B–D, arrows) and other regions of
the brain (Figure 3A, arrowheads), suggesting a heterogeneity
of vesicular ATP-accumulating cells in the brain. Together,
these findings signify that the machinery required for vesicular
ATP release is present on DA neurons in different regions of
the CNS.
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FIGURE 2 | VNUT-immunoreactive cells co-localize with tyrosine-hydroxylase positive dopaminergic amacrine/interplexiform cells. Vertical cryostat
sections of (A) adult mouse and (C) rat retinae expressed VNUT-IR in an amacrine/interplexiform cell (IPC) type in the INL. Pre-incubation of the VNUT antibodywith excess
peptide antigen resulted in no immunoreactivity, confirming the specificity of the antibody in the (B)mouse and (D) rat retinas. (E–J) VNUT immunoreactivity (green) was
exclusively expressed in tyrosine hydroxylase-labeled dopaminergic amacrine/IPC cells and processes (red) as shown in a vertical section (E–G) and flatmounted mouse
retina (H–J). Arrows (A, E–G) indicate interplexiform processes co-labeled with VNUT and TH extending toward the OPL. Arrowheads (A) indicate processes extending
towards the IPL. ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer. Scale bars = 20µm.
In the Retina VNUT-IR IPC Processes are Closely
Associated with Horizontal Cells and Cone
Photoreceptors
In the retina, amacrine/interplexiform cells (IPCs) have been
extensively reported to form close contacts (synaptic and close
appositions) with photoreceptors, horizontal and bipolar cells
within the OPL, providing a centrifugal pathway from the
inner to the outer plexiform layers via the release of dopamine
(Dowling and Ehinger, 1975; Kolb et al., 1990), GABA (Kolb
et al., 1991; Witkovsky et al., 2008; Dedek et al., 2009) and
glycine (Pow and Hendrickson, 1999; Haverkamp and Wassle,
2000). To better illustrate VNUT-IR processes at multiple levels
of the neural retina, three-dimensional reconstruction of retinal
flatmounts immunolabeled with VNUT were performed. The
three-dimensional top view of the confocal acquired flatmount
image (Figure 4A) shows many VNUT varicosities at the border
of the INL and IPL, directly beneath the VNUT cell soma
(Figure 4B). In addition to the dense plexus that was largely
restricted to the outermost layer of the IPL (sublamina 1), VNUT
processes were found to extend to the inner sublaminae of the
IPL (open arrow) and distally across the INL toward the OPL
(Figure 4C, solid arrow). This data further verifies that VNUT
is expressed in IPCs in the mouse retina.
To determine the cellular associations of VNUT-IR
amacrine/IPCs in the OPL, three-dimensional reconstructions
of confocal acquired flatmounts co-labeled with VNUT and
the cone photoreceptor label, peanut-agglutinin (PNA), or
the horizontal cell label, calbindin were examined. VNUT-IR
amacrine/IPC distal processes were found in close association
with PNA-labeled cone photoreceptor terminals (Figure 4D),
such that VNUT-IR profiles were found immediately beneath
and extending through cone terminals (Figure 4E). VNUT-IPC
distal processes were also found in close apposition to calbindin-
labeled horizontal cells, showing intricate contacts with the
plexus of horizontal cell processes in the OPL (Figure 4F). These
findings suggest that VNUT-expressing amacrine/IPCs have the
capacity to interact with photoreceptors and horizontal cells in
the outer retina.
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FIGURE 3 | VNUT-immunoreactive cells co-localize with tyrosine-hydroxylase positive dopaminergic neurons in the mouse substantia nigra and
ventral tegmental area. (A) A coronal section of the mouse midbrain co-labeled with VNUT (green) and Tyrosine Hydroxylase (TH, red) showing co-localization on
dopaminergic neurons in the substantia nigra (SN) and ventral tegmental area (VTA). Arrowheads indicate VNUT+TH− cells. (B–D) A magnified view of the SN (right
inset) showing all TH-positive cells (red) are also positive for VNUT (green). Arrows in (B–D) indicate VNUT+TH− cells. (E–G) A magnified view of the VTA (left inset)
showing VNUT expression (green) in all TH-positive cells (red). VNUT expression was not restricted to DA neurons and was found in many TH-negative cells
throughout this region of the brain. Scale bars = 500µm (A), 100µm (B–D) and 50µm (E–G).
ATP is Released from Dopaminergic Neurons of
the Retina
In order to confirm that VNUTwas involved in the accumulation
and release of ATP within dopaminergic amacrine/IPCs, a
series of functional assays were undertaken using freshly
dissociated retinal preparations. Neuronal preparations were
labeled for VNUT-IR, fluorescent ATP markers (Mant-ATP or
quinacrine) and the fluorescent dopamine marker (FFN102)
and viewed on a confocal microscope (Figure 5). VNUT-
positive neurons were infrequent in the retinal preparation,
confirming the limited expression in retinal vertical sections
(Figure 2A). Those cells expressing VNUT were found to load
the fluorescent ATP markers, Mant-ATP (Figures 5A–D) and
quinacrine (Figures 5E–H), in discrete puncta. Quantitative
analysis indicated there were slightly more VNUT positive
puncta than fluorescent ATP puncta within each cell (2778 ±
167 vs. 2399 ± 36 puncta/100µm2 of cell; n = 12 cells;
Student’s t-test, p = 0.03) and that 74 ± 1% of the VNUT
puncta were co-localized with ATP fluorescence, suggesting
that some VNUT positive/ATP negative puncta exist, perhaps
representing early vesicles. Within these cells also, 80 ± 8% of
the dopamine fluorophore, FFN102 puncta co-localized with the
fluorescent ATP marker puncta (n = 12 cells), suggesting co-
loading of ATP and dopamine in vesicles within VNUT-positive
neurons. However, detailed analysis at the ultrastructural level
would be required to confirm this. All cells that were positive
for VNUT were also positive for fluorescent ATP- and the
dopamine-marker.
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FIGURE 4 | VNUT-immunoreactive amacrine/interplexiform cell processes are closely associated with cone photoreceptor terminals and horizontal
cells in the outer retina. (A) Confocal z-stack of a retinal flatmount immuno-labeled with VNUT, showing specific expression in a cell in the inner retina with long
primary dendrites and fine processes. (B) Three-dimensional (3D) reconstruction of the confocal z-stack in (A) showing a dense network of processes extending
laterally beneath the cell soma. (C) Side projection of the 3D reconstructed VNUT-positive cell showing that most processes are distributed in a narrow horizontal
plane at the distal portion of the IPL. The white solid arrow indicates an interplexiform process reaching toward the outer retina. The open arrow indicates processes
extending into the proximal portion of the IPL. (D) Three-dimensional (3D) reconstruction of a confocal z-stack showing a VNUT interplexiform process (green) in the
OPL closely associated with cone photoreceptor terminals labeled with peanut agglutinin (PNA, red). (E) A magnified view of a VNUT interplexiform process (green) in
close association with a cone terminal (red). (F) 3D reconstruction of a flatmount confocal z-stack co-labeled with VNUT (green) and the horizontal cell (HC) marker,
calbindin (red). The VNUT interplexiform process was found in close apposition with horizontal cell processes in the OPL. OPL, outer plexiform layer; INL, inner nuclear
layer; IPL, inner plexiform layer. Scale bars = 20µm (A), 30µm (B,C), 5µm (D), 2µm (E), and 3µm (F).
Following the above phenotypic characterization, the
capacity of these dopamine/VNUT-containing cells to release
ATP was assessed by quantifying changes in ATP-marker
fluorescence intensity near the cell membrane (Figure 6). For
these experiments, quinacrine was used as this ATP-marker
was the most stable when no treatment was applied, specifically
fluorescence intensity did not reduce significantly over the
recording interval when quantified (Figure 6M, black line, n = 8
cells). Similarly, under basal conditions, when a volume of PSS
was added to account for slight defocus changes due to volume
alterations, fluorescence intensity did not reduce significantly
over the recording interval (Movie 1-PSS; Figures 6A–D,M,
red line, n = 8 cells). In order to stimulate ATP release, high
K+/low Na++ conditions (55mM K+-PSS) were used and found
to reduce ATP-marker fluorescence at the cell membrane within
a second after addition (Movie 2-highK-1 andMovie 3-highK-2;
arrows in Figures 6E–H). The change in fluorescence was
significantly reduced to 50% of baseline (Figure 6M, green line,
n = 10 cells). This K+-PSS induced-change in ATP-marker
fluorescence was blocked in the presence of cadmium, suggesting
that this response was voltage gated Ca++ channel dependent
exocytosis (Movie 4-highK-Cd; Figures 6I–J,M, n = 10 cells).
Finally, ATP release was quantified in this dissociated retinal
cell population using a commercial ATP assay (ENLITEN R©
ATP Assay; Figure 6N). After addition of vehicle (PSS), the
basal release of ATP was determined to be 25 pM over a 20 s
epoch. Application of the depolarizing solution (55mMK+-PSS)
induced a significant increase in ATP release to 75 pM (n = 5
separate neuronal preparations, One-Way ANOVA, p < 0.05).
This high potassium-induced increase in ATP release was
blocked when the retinal cell preparation was pre-treated with
cadmium. This suggests that in response to a depolarizing
stimulus, ATP release from retinal preparations relies on Ca++
dependant exocytosis. Together these findings suggest that
dopaminergic neurons of the retina express VNUT, load ATP
into vesicles and when stimulated, release ATP via exocytosis.
Discussion
In this study, VNUT expression was characterized in the mouse
retina and brain based on RNA transcript, protein and functional
analysis. Our results demonstrate, for the first time, that VNUT
expression is apparent in DA-cells of the rodent retina and
midbrain suggesting that ATP is stored and released by way
of exocytosis from DA cells across the CNS. In the retina,
VNUT-IR amacrine/IPC processes were closely associated with
cone photoreceptor terminals and horizontal cell processes,
suggesting that these cells may modulate outer retinal processing
via regulated exocytosis of ATP.
Two Native Isoforms of VNUT Occur in the Mouse
Retina and Brain
In addition to a full length Slc17a9 transcript (NM_183161),
putative protein coding isoforms based on automated
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FIGURE 5 | VNUT-immunoreactive dissociated retinal neurons co-load fluorescent ATP- and dopamine-markers in vesicles. Freshly dissociated retinal
preparations were labeled for VNUT-immunoreactivity (red) and incubated with fluorescent ATP markers (green) and the fluorescent dopamine marker (FFN102, blue).
(A–D) VNUT-positive neurons (A, red) co-expressed the fluorescent ATP marker Mant-ATP (B, green) and the dopamine fluorophore FFN102 (C, blue) in discrete
puncta (D, co-localized). (E–H) Similarly VNUT-positive neurons (E, red) co-expressed the fluorescent ATP marker quinacrine (F, green) and the dopamine fluorophore
FFN102 (G, blue) in discrete puncta (H, co-localized). Within these cells, the fluorescent ATP marker puncta co-localized with the dopamine fluorophore, FFN102,
suggesting co-loading of ATP and dopamine in vesicles within VNUT-positive neurons. Scale bar = 2.5µm.
computational analysis have recently been predicted (X1,
XM_006500589; X2, XM_006500590; X3, XM_006500591).
Our data indicate that two protein coding mRNA variants are
expressed in the mouse central nervous system, with products
corresponding to the full length Slc17a9 and X1/X2 isoform
identified. The putative Slc17a9 X3 isoform was not detected in
the retina or midbrain. In line with the presence of these gene
transcripts, two protein bands of∼75 and∼50 kDa were isolated
in mouse retinal and cortical preparations using Western blot.
Based on the sequence location of the antigen peptide, the
novel guinea pig VNUT antibody used should recognize both
full length and X1/X2 protein, but not X3 protein. The 75 kDa
band correlates with the molecular weight reported previously
for full length VNUT (Sawada et al., 2008; Larsson et al., 2012;
Hiasa et al., 2014), whereas the smaller ∼50 kDa band likely
represents isoform X1/X2. Further work is necessary to identify
whether these isoforms play differential roles in modulating
synaptic vesicle loading and release. In addition, if there is cell
specific isoform expression across differing cell types within the
central nervous system, this may unveil further complexity in the
purinergic neurotransmission system.
VNUT in the Midbrain
Co-localization of dopamine with other transmitters is a
common phenomenon in the CNS; GABA and glutamate are
expressed in subpopulations of neurons of the substantia nigra
and VTA, respectively (Kaneko et al., 1990; Campbell et al.,
1991; Sulzer et al., 1998). Furthermore, ATP and dopamine co-
transmission from neurons in the midbrain has been reported
(Krügel et al., 2001, 2003). Our results indicate that all DA
neurons in the substantia nigra and VTA of the mouse midbrain
co-express VNUT, suggesting that DA neurons are indeed a
source of extracellular ATP and thus its bioactive degradation
products such as ADP and adenosine. These purinergic ligands
would mediate their actions on purine-receptors (P1 and P2)
which have been found to be expressed pre-synaptically on
DA neurons and also co-expressed with dopamine receptors
on neurons in brain regions receiving DAergic input (Amadio
et al., 2007; Morin and Di Paolo, 2014). As DA neurons in
the midbrain modulate a broad range of behaviors, such as
motor control, motivation and response to rewards (Wise, 2008;
Joshua et al., 2009; Schultz, 2013; Cachope and Cheer, 2014),
it is likely that purinergic neurotransmission plays a role in
these pathways. Similarly, purinergic transmission is likely to
have a role in neurological disorders that involve dysregulation
of DAergic neurons in the substantia nigra, such as Parkinson’s
disease (Benazzouz et al., 2014). This proposal is consistent with
the evidence for the therapeutic effect of adenosine receptor
antagonists in the treatment of this disease (Kulisevsky and
Poyurovsky, 2012; Jenner, 2014). VNUT-IR was not restricted to
DA cells, but was also expressed by non-DA neurons within the
substantia nigra. As VNUT has been shown to co-localize with
glutamatergic neurons in the hippocampus (Larsson et al., 2012),
further research is required to elucidate the cellular expression
profile of non-DAergic/VNUT positive cells in the midbrain.
The discovery of VNUT-IR within the substantia nigra and VTA
provides a newmarker for assessing functional subpopulations of
cells in these brain areas.
VNUT in the Retina
Analogous to the brain, VNUT expression was found in all
TH-positive somata and processes in the retina, indicating that
ATP release from DA neurons may be a common feature across
the CNS. The DA amacrine/IPCs were the only cell class in
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FIGURE 6 | ATP is released by calcium dependent exocytosis from VNUT positive retinal neurons. Changes in ATP-marker fluorescence intensity near the
cell membrane were assessed as an indicator of ATP release under various treatment conditions. Quinacrine (green) was used as this ATP-marker was the most
stable. Retinal neurons were immuno-labeled with VNUT (red). (A–D) Images collected and shown over a 30 s interval under basal conditions, when vehicle (PSS) was
added at 15 s. Fluorescence intensity near the membrane was not altered over the recording interval (M, red line, n = 8 cells). (E–H) Images collected over a 25 s
interval under depolarizing-conditions, where 55mM K+-PSS added at 13 s. Quinacrine fluorescence at the cell membrane reduced significantly within a second after
stimulation (M, green line, n = 10 cells). Arrowheads indicate a reduction of ATP-marker fluorescence at the cell membrane. (I–L) Images collected over a 44 s time
interval under depolarizing-conditions in the presence of cadmium Cd++ (55mM K+-PSS added at 16 s). There was no significant change in fluorescence intensity
near the membrane in the presence of Cd++ (M, blue line, n = 10 cells). (N) ATP release from the dissociated retinal cells (n = 5 separate neuronal preparations) was
determined under basal (PSS, red), depolarizing stimuli (K+, green) and depolarizing stimuli following pre-treatment with cadmium (K+Cd++, blue). The level of
extracellular ATP was significantly increased with the addition of K+-PSS, while blockade of voltage-gated Ca++ channels with Cd++ showed comparable levels of
ATP release to the basal condition. Scale bars = 7.5µm. PPS, physiological saline solution; K+, potassium (55mM); Cd++, Cadmium (400µM). *p < 0.01.
the retina to express VNUT, suggesting that in addition to
dopamine and GABA (Hirasawa et al., 2012), these cells also
co-release ATP. Further functional analysis of these VNUT-IR
cells indicated that dopamine and ATP are likely co-expressed
in vesicles within these cells and released via calcium dependent
exocytosis upon treatment with a depolarizing stimulus. Previous
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work suggests that there are at least two classes of DA neuron
in the mammalian retina (Nguyen-Legros et al., 1997; Zhang
et al., 2007). Morphologically, these cells have somata in the
INL, directly adjacent to the IPL and give rise to three dendritic
plexuses, two in the IPL in strata 1 and 3, and one in the OPL,
an interplexiform-process (Hirasawa et al., 2012). Within the
OPL, these cells modulate photoreceptor terminals, horizontal
and bipolar cells, providing centrifugal input from the inner to
the outer retina (Dowling and Ehinger, 1975; Frederick et al.,
1982).
Based on DA cell morphology and DA receptor distribution
it is anticipated that DA modulates cell activity in the outer
retina by both synaptic and extrasynaptic neurotransmission
(Dacey, 1990; Kolb et al., 1990; Savy et al., 1995). Evidence for
extrasynaptic transmission comes primarily from the finding
that DA-IPC processes do not necessarily correlate with
the expression pattern of DA receptors (Bjelke et al., 1996;
Witkovsky, 2004). Similar mechanisms of action may apply for
ATP release in the OPL. Evidence for synaptic neurotransmission
comes from the close proximity of VNUT-IR IPC varicosities
with horizontal cell processes and cone photoreceptor terminals,
which express ATP sensitive, P2X-receptors (P2X3-R, P2X4-R,
P2X7-R; Puthussery and Fletcher, 2004; Puthussery et al., 2006;
Vessey and Fletcher, 2012; Ho et al., 2014). As ATP would be
rapidly hydrolyzed to ADP, protons and adenosine by enzymes
located between synapses in the OPL (Puthussery et al., 2006;
Puthussery and Fletcher, 2007), it would be imperative that
traditional synaptic transmission occurs for these ATP sensitive
receptors to be activated. Extrasynaptic purinergic transmission,
mediated by adenosine on P1 receptors is also a likely mode
of action. Indeed recent evidence indicates that A2a adenosine
receptors are expressed by photoreceptors and activation of these
receptors increases photoreceptor coupling, opposing the action
of dopamine on DR4-receptors in modulating the adaptation
state of the retina (Li et al., 2013). As there is also evidence
that dopamine reduces the receptive field size of horizontal cells
by uncoupling gap junctions in this cell class in various species
(Hampson et al., 1994; He et al., 2000; Reitsamer et al., 2006;
Zhang et al., 2011), it is tempting to speculate that ATP may
share similar roles with dopamine in setting the gain of the retina.
Interestingly, a second, moderate speed (200ms) extrasynaptic
role for ATP appears to exist, whereby the rapid degradation of
ATP to ADP and protons, increases the pH of the synaptic cleft
providing feedback to horizontal cells and cones (Vroman et al.,
2014). Thus, vesicular release of ATP in the OPL may mediate
fast synaptic transmission via P2X-and P2Y-receptors, moderate
speed modulation via pH-regulation and slow diffuse activation
of P1-adenosine sensitive receptors, thereby playing a myriad of
roles in modulating photoreceptors, horizontal cells and bipolar
cells.
Given the widespread distribution of multiple purinergic
receptor subtypes in the OPL and throughout all layers of the
IPL in the retina (Puthussery and Fletcher, 2004; Puthussery
et al., 2006; Ward et al., 2008; Vessey and Fletcher, 2012;
Zhang et al., 2012; Ho et al., 2014), it was surprising to find
that vesicular ATP storage and release was restricted to a
single cell class that accounts for less than 1% of the retinal
cell population (Gustincich et al., 1997; Jeon et al., 1998).
One possibility is that other retinal cells with the potential
for ATP release, such as cholinergic amacrine cells (Neal and
Cunningham, 1994; Santos et al., 1999), horizontal cells (Vroman
et al., 2014) and Müller glial cells (Newman and Zahs, 1998;
Newman, 2003, 2015), may express as yet unidentified vesicular
ATP transporters. Given the close phylogenetic relationships
and structural similarities between SLC17A9 and the other
members of the SLC17 gene family (Sreedharan et al., 2010;
Reimer, 2013), and the fact that not all of these transporters
have been functionally characterized, it is highly likely that
other vesicular ATP transporters may also exist. In addition
to the existence of other ATP transporters, contributions from
conductive mechanisms such as pannexin, connexin and Cl−
anion channels cannot be ruled out (Lazarowski, 2012;Mutafova-
Yambolieva and Durnin, 2014; Vroman et al., 2014). Thus, while
our data suggest that DA-amacrine/IPCs are a source of vesicular
ATP released by exocytosis in the mouse retina, it is possible that
other mechanisms of release may also occur.
Conclusion
In summary, this study presents evidence for a source of
vesicular released ATP in the mouse retina and midbrain. We
demonstrated that VNUT is expressed by DA-amacrine/IPCs in
the retina, and DA as well as non-DA neurons in the midbrain.
In addition to dopamine and GABA, our results suggest that
retinal-IPCs may modulate outer retinal processing via the
release of ATP at contact sites with horizontal cell processes and
photoreceptor terminals. These results provide further evidence
for a role of purines in neurotransmission in the retina and the
brain.
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Movie 1 | Confocal imaging of a retinal neuron positive for VNUT
(red) and fluorescent ATP marker (green) shown over a 30 s
interval under basal conditions, when vehicle (PSS) was added at
15 s. Fluorescence intensity near the membrane was not altered over the
recording interval.
Movie 2 | Confocal imaging of a retinal neuron positive for VNUT (red) and
fluorescent ATP marker (green) shown over a 25 s interval under
depolarizing-conditions, where 55mM K+-PSS was added at 13 s.
Quinacrine fluorescence at the cell membrane reduced significantly within a
second after stimulation.
Movie 3 | Another series of confocal imaging of a retinal neuron positive
for VNUT (red) and fluorescent ATP marker (green) shown over a 45 s
interval under depolarizing-conditions, where 55mM K+-PSS was added
at 31 s. Quinacrine fluorescence at the cell membrane reduced significantly within
a second after stimulation.
Movie 4 | Confocal imaging of a retinal neuron positive for VNUT (red) and
fluorescent ATP marker (green) shown over a 44 s time interval under
depolarizing-conditions in the presence of cadmium Cd++ (55mM
K+-PSS added at 16 s). There was no significant change in fluorescence
intensity near the membrane in the presence of cadmium.
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